AMA on vitamin D intake
This article was originally published in The Tan Sheet
Executive SummaryThe American Medical Association calls for FDA to re-examine the Daily Reference Intake Value for vitamin D, according to a June 17 release. Current research on the benefits of vitamin D, including strong bones and reduced breast cancer risk, suggests the prevailing upper limit for adults, which was set in 1997, is "likely overly conservative," AMA says...
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.